Philips Expands Benelux Home Healthcare Offering

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is expanding its focus on home healthcare with an innovative home medication dispensing service designed to support chronically ill patients and care providers. The new service provides automated, compact dispensers loaded with personalized pre-packaged medication and features a dedicated web-based IT connection to the patient's care giver organization and pharmacist. Building on its broad portfolio of home health care capabilities Philips, is now rolling out its new service in the Netherlands, Belgium and Luxembourg (Benelux). With the new service, Philips is expanding its home healthcare activities in the Benelux to home care, elderly care and nursing home organizations.

By offering the prescribed medication at the preprogrammed time, as well as monitoring and support, the service aims to increase medication adherence among seniors and chronically ill patients. This could improve their health and quality of life, while reducing avoidable hospital stays, adverse events and healthcare costs, and supporting healthcare organizations.

Each time medication is due, the dispenser automatically reminds the person, checks it is the right medication at the right time and then releases and opens individual pouches according to the patient’s prescribed regimen. This motivates the patient to adhere to personal medication plans and minimizes the risk of taking the wrong medication or dose. The solution monitors medication usage and remotely alerts nursing staff when medication is not taken, helping to streamline the normally time-consuming task of medication management and allowing them to focus on additional care issues.

"Technology-enabled care at home will play an increasingly important role in helping care providers cope with the pressing challenges presented by rising numbers of people with chronic conditions," said Henk Valk, General Manager Philips Healthcare Benelux. "For more than a decade, Philips has been a pioneer in the home healthcare market in the Netherlands, and we are continuously looking to expand our offering through collaborations, innovative technologies and services that can make a difference where it matters for patients, their families and healthcare providers."

"Poor medication adherence is relatively common and has dramatic effects on individual and population-level health," said Dick Herfst, CEO of ZZG zorggroep, a Dutch home care, elderly care and nursing home organization that is already using the initial version of the service. "Helping clients take their medication correctly and in time is an important, but often time-consuming task for our community nurses. With the help of this medication dispensing service, we see clients are more compliant and independent while their relatives feel more comfortable."

As people live longer, chronic illness is increasingly common and places a growing burden on healthcare systems. Home healthcare provides new cost effective ways to support seniors and chronically ill patients while retaining an independent lifestyle. Studies show that around 50% of medication for chronic disease is not taken as prescribed [1]. Each year in the Netherlands, 19.000 potentially avoidable hospitalizations involve elderly people who took their medication incorrectly, adding up to an annual financial burden of EUR 85 million [2].

The home medication dispensing service for the Benelux differs from the medication dispensing service that Philips already offers in the United States, as it is based on a medication pouches system that is standardized and broadly available in the Netherlands. To bring the solution to market in the Netherlands, Philips is collaborating with the Dutch pharmaceutical telehealth company Innospense, that initially developed the integrated medication dispensing service, and is assisted by e-health implementation provider Focus Cura. Philips will also work with pharmacies to ensure the patient’s prescribed regimen is synchronized with the intelligent dispensing device in the patient's home.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

1. Closing the Quality Gap Series: Medication Adherence Interventions: Comparative Effectiveness Hospitals Admissions
2. Related to Medication (HARM study), Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, 2006

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...